Literature DB >> 728327

Deprenyl is metabolized to methamphetamine and amphetamine in man.

G P Reynolds, J D Elsworth, K Blau, M Sandler, A J Lees, G M Stern.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 728327      PMCID： PMC1429688          DOI： 10.1111/j.1365-2125.1978.tb00883.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  14 in total

1.  Biochemical theories of schizophrenia. I.

Authors:  S S KETY
Journal:  Science       Date:  1959-06-05       Impact factor: 47.728

2.  Comparative pharmacological analysis of the optical isomers of phenyl-isopropyl-methyl-propinylamine (E-250).

Authors:  K Magyar; E S Vizi; Z Ecseri; J Knoll
Journal:  Acta Physiol Acad Sci Hung       Date:  1967

3.  Dopamine is a monoamine oxidase B substrate in man.

Authors:  V Glover; M Sandler; F Owen; G J Riley
Journal:  Nature       Date:  1977-01-06       Impact factor: 49.962

Review 4.  The metabolism of amphetamines in mammals.

Authors:  J Caldwell
Journal:  Drug Metab Rev       Date:  1976       Impact factor: 4.518

5.  Evidence that deprenyl, A type B monoamine oxidase inhibitor, is an indirectly acting sympathomimetic amine.

Authors:  L L Simpson
Journal:  Biochem Pharmacol       Date:  1978       Impact factor: 5.858

6.  Clinical trial of a new type promptly acting psychoenergetic agent (phenyl-isopropyl-methylpropinyl-HCl, "E-250").

Authors:  E Varga; L Tringer
Journal:  Acta Med Acad Sci Hung       Date:  1967

7.  Urinary excretion of methylamphetamine in man.

Authors:  A H Beckett; M Rowland
Journal:  Nature       Date:  1965-06-19       Impact factor: 49.962

8.  Phenethylamines in brain and liver of rats with experimentally induced phenylketonuria-like characteristics.

Authors:  D J Edwards; K Blau
Journal:  Biochem J       Date:  1973-01       Impact factor: 3.857

9.  Implications of combined treatment with 'Madopar' and L-deprenil in Parkinson's disease. A long-term study.

Authors:  W Birkmayer; P Riederer; L Ambrozi; M B Youdim
Journal:  Lancet       Date:  1977-02-26       Impact factor: 79.321

10.  Deprenyl in Parkinson's disease.

Authors:  A J Lees; K M Shaw; L J Kohout; G M Stern; J D Elsworth; M Sandler; M B Youdim
Journal:  Lancet       Date:  1977-10-15       Impact factor: 79.321
View more
  54 in total

1.  Cytoprotective effect of (-)-deprenyl, (-)desmethyl-deprenyl and (-)deprenyl-N-oxide on glutathione depleted A-2058 melanoma cells.

Authors:  B Szende; G Barna; Kálmán Magyar
Journal:  J Neural Transm (Vienna)       Date:  2010-05-09       Impact factor: 3.575

2.  R-deprenyl: pharmacological spectrum of its activity.

Authors:  K Magyar; B Szende; V Jenei; T Tábi; M Pálfi; E Szöko
Journal:  Neurochem Res       Date:  2010-08-20       Impact factor: 3.996

3.  Restoration and putative protection in Parkinsonism.

Authors:  T Archer; A Fredriksson
Journal:  Neurotox Res       Date:  2000       Impact factor: 3.911

4.  Cardiovascular responses to combined treatment with selective monoamine oxidase type B inhibitors and L-DOPA in the rat.

Authors:  J P M Finberg; A Gross; O Bar-Am; R Friedman; Y Loboda; M B H Youdim
Journal:  Br J Pharmacol       Date:  2006-10-03       Impact factor: 8.739

5.  Fatal bupropion overdose with post mortem blood concentrations.

Authors:  Henry A Spiller; Edward Bottei; Linda Kalin
Journal:  Forensic Sci Med Pathol       Date:  2007-08-22       Impact factor: 2.007

6.  Relation between brain monoamine oxidase (MAO) activity and the firing rate of locus coeruleus neurons.

Authors:  L Oreland; G Engberg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-07       Impact factor: 3.000

Review 7.  The Role of Metabolites of Antidepressants in the Treatment of Depression.

Authors:  M V Rudorfer; W Z Potter
Journal:  CNS Drugs       Date:  1997-04       Impact factor: 5.749

8.  Pharmacokinetic and neurochemical studies on N-propargyl-2-phenylethylamine, a prodrug of 2-phenylethylamine.

Authors:  T S Rao; G B Baker; R T Coutts
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-07       Impact factor: 3.000

9.  Phenylethylamine-induced stereotypies in the rat: a behavioral test system for assessment of MAO-B inhibitors.

Authors:  R Ortmann; M Schaub; A Felner; J Lauber; P Christen; P C Waldmeier
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

10.  Absence of "cheese effect" during deprenyl therapy: some recent studies.

Authors:  M Sandler; V Glover; A Ashford; G M Stern
Journal:  J Neural Transm       Date:  1978       Impact factor: 3.575
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.